Boston Scientific Ownership
| BSX Stock | USD 90.75 0.54 0.60% |
Shares in Circulation | First Issued 1991-03-31 | Previous Quarter 1.5 B | Current Value 1.5 B | Avarage Shares Outstanding 1.1 B | Quarterly Volatility 394.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Boston |
Boston Stock Ownership Analysis
About 92.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.62. Boston Scientific Corp had not issued any dividends in recent years. The entity had 2:1 split on the 6th of November 2003. Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. Boston Scientific operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 41000 people. For more info on Boston Scientific Corp please contact Michael Mahoney at 508 683 4000 or go to https://www.bostonscientific.com.Besides selling stocks to institutional investors, Boston Scientific also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Boston Scientific's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Boston Scientific's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Boston Scientific Quarterly Liabilities And Stockholders Equity |
|
Boston Scientific Insider Trades History
Less than 1% of Boston Scientific Corp are currently held by insiders. Unlike Boston Scientific's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Boston Scientific's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Boston Scientific's insider trades
Boston Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Boston Scientific is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Boston Scientific Corp backward and forwards among themselves. Boston Scientific's institutional investor refers to the entity that pools money to purchase Boston Scientific's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main | 2024-09-30 | 21.8 M | Capital World Investors | 2024-09-30 | 21.7 M | Bollard Group Llc | 2024-06-30 | 21.7 M | Hhg Plc | 2024-06-30 | 18.3 M | Norges Bank | 2024-06-30 | 17.9 M | Franklin Resources Inc | 2024-09-30 | 15.9 M | Amundi | 2024-06-30 | 15.4 M | Bank Of New York Mellon Corp | 2024-06-30 | 14.8 M | Legal & General Group Plc | 2024-06-30 | 13.9 M | Fmr Inc | 2024-09-30 | 135.2 M | Vanguard Group Inc | 2024-09-30 | 131.3 M |
Boston Scientific Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Boston Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Boston Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Boston Scientific insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Joseph Fitzgerald 2 days ago Disposition of 11236 shares by Joseph Fitzgerald of Boston Scientific subject to Rule 16b-3 | ||
Arthur Butcher 3 days ago Disposition of 14010 shares by Arthur Butcher of Boston Scientific at 89.2694 subject to Rule 16b-3 | ||
Wendy Carruthers over two months ago Disposition of 1197 shares by Wendy Carruthers of Boston Scientific at 24.55 subject to Rule 16b-3 | ||
Wendy Carruthers over six months ago Disposition of 6983 shares by Wendy Carruthers of Boston Scientific at 66.89 subject to Rule 16b-3 | ||
Daniel Brennan over six months ago Disposition of 1644 shares by Daniel Brennan of Boston Scientific at 65.82 subject to Rule 16b-3 | ||
Tobin James R over a year ago Exercise or conversion by Tobin James R of 100000 shares of Boston Scientific subject to Rule 16b-3 |
Boston Scientific's latest congressional trading
Congressional trading in companies like Boston Scientific Corp, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Boston Scientific by those in governmental positions are based on the same information available to the general public.
| 2023-11-01 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-31 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-12 | Senator Markwayne Mullin | Acquired $15K to $50K | Verify | ||
| 2022-11-05 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
| 2021-02-10 | Representative Alan S Lowenthal | Acquired $1,001 - | Verify | ||
| 2020-04-28 | Representative Alan S Lowenthal | Acquired $1,001 - | Verify | ||
| 2020-03-17 | Representative Alan S Lowenthal | Acquired Under $15K | Verify |
Boston Scientific Outstanding Bonds
Boston Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Boston Scientific Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Boston bonds can be classified according to their maturity, which is the date when Boston Scientific Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAZ73 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAY09 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAX26 | View | |
| BXP 675 01 DEC 27 Corp BondUS10112RBG83 | View | |
| BOSTON SCIENTIFIC P Corp BondUS101137AL15 | View | |
| BXP 245 01 OCT 33 Corp BondUS10112RBF01 | View | |
| BOSTON PROPERTIES LP Corp BondUS10112RBE36 | View |
Boston Scientific Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 1st of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.